Anteris Technologies (AU:AVR) has released an update.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Anteris Technologies Ltd is gearing up for a significant milestone as its Holdco shares are set to commence trading on Nasdaq, marking a pivotal step in its corporate restructuring. The company, known for its innovative DurAVR® transcatheter heart valve, is transitioning into a Delaware corporation to enhance its market reach. This move is expected to boost investor interest and expand its footprint in the MedTech space.
For further insights into AU:AVR stock, check out TipRanks’ Stock Analysis page.